Research ArticleCardiology

Activin type II receptor signaling in cardiac aging and heart failure

See allHide authors and affiliations

Science Translational Medicine  06 Mar 2019:
Vol. 11, Issue 482, eaau8680
DOI: 10.1126/scitranslmed.aau8680

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.

Compose eLetter

Plain text

  • Plain text
    No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

  • RE: ActRII may be Increased by Loss of Testosterone

    I suggest the findings of Roh, et al., may be explained by the loss of testosterone with aging. A case may be made in the literature that ActRII is increased with androgen. Activin is also negatively associated with testosterone. Additionally, a case may also be made within the literature that, actually, heart disease of aging results from the natural loss of testosterone.

    Competing Interests: None declared.

Stay Connected to Science Translational Medicine

Navigate This Article